H. D?-ohner, D. Weisdorf, and C. Bloomfield, Acute Myeloid Leukemia, New England Journal of Medicine, vol.373, issue.12, pp.1136-52, 2015.
DOI : 10.1056/NEJMra1406184

G. Poste, Bring on the biomarkers, Nature, vol.94, issue.7329, pp.156-163, 2011.
DOI : 10.1016/j.healthpol.2009.09.006

M. Buyse, D. Sargent, A. Grothey, A. Matheson, and A. De-gramont, Biomarkers and surrogate end points???the challenge of statistical validation, Nature Reviews Clinical Oncology, vol.3, issue.6, pp.309-326, 2010.
DOI : 10.1200/JCO.2007.14.5144

D. Grimwade, H. Walker, F. Oliver, K. Wheatley, C. Harrison et al., The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial, Blood, vol.92, pp.2322-339746770, 1998.

D. Grimwade, H. Walker, G. Harrison, F. Oliver, S. Chatters et al., The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial, Blood, vol.98, issue.5, pp.1312-1332, 2001.
DOI : 10.1182/blood.V98.5.1312

H. Dohner, E. Estey, S. Amadori, F. Appelbaum, T. Buchner et al., Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet, Blood, vol.115, issue.3, pp.453-74, 2009.
DOI : 10.1182/blood-2009-07-235358

M. Stelljes, U. Krug, D. Beelen, J. Braess, M. Sauerland et al., Allogeneic Transplantation Versus Chemotherapy as Postremission Therapy for Acute Myeloid Leukemia: A Prospective Matched Pairs Analysis, Journal of Clinical Oncology, vol.32, issue.4, p.5768, 2013.
DOI : 10.1200/JCO.2013.50.5768

J. Koreth, R. Schlenk, K. Kopecky, S. Honda, J. Sierra et al., Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission, JAMA, vol.301, issue.22, pp.2349-61813, 2009.
DOI : 10.1001/jama.2009.813

J. Cornelissen and D. Blaise, Hematopoietic stem cell transplantation for patients with AML in first complete remission, Blood, vol.127, issue.1, pp.62-70, 2016.
DOI : 10.1182/blood-2015-07-604546

D. Grimwade, R. Hills, A. Moorman, H. Walker, S. Chatters et al., Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials, Blood, vol.116, issue.3, pp.354-65, 2009.
DOI : 10.1182/blood-2009-11-254441

J. Patel, M. G?-onen, M. Figueroa, H. Fernandez, Z. Sun et al., Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia, New England Journal of Medicine, vol.366, issue.12, pp.1079-89, 2012.
DOI : 10.1056/NEJMoa1112304

E. Lion, Y. Willemen, Z. Berneman, V. Tendeloo, V. Smits et al., Natural killer cell immune escape in acute myeloid leukemia, Leukemia, vol.34, issue.9, pp.2019-2045, 2012.
DOI : 10.1046/j.1365-2249.2001.01692.x
URL : http://www.nature.com/leu/journal/v26/n9/pdf/leu201287a.pdf

F. Donskov, V. Der-maase, and H. , Impact of Immune Parameters on Long-Term Survival in Metastatic Renal Cell Carcinoma, Journal of Clinical Oncology, vol.24, issue.13, 1997.
DOI : 10.1200/JCO.2005.03.9594

J. Galon, A. Costes, F. Sanchez-cabo, A. Kirilovsky, B. Mlecnik et al., Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome, Science, vol.313, issue.5795, pp.1960-1964, 2006.
DOI : 10.1126/science.1129139

B. Mlecnik, G. Bindea, H. Angell, P. Maby, M. Angelova et al., Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability, Immunity, vol.44, issue.3, pp.698-711, 2016.
DOI : 10.1016/j.immuni.2016.02.025

B. Mlecnik, M. Tosolini, A. Kirilovsky, A. Berger, G. Bindea et al., Histopathologic-Based Prognostic Factors of Colorectal Cancers Are Associated With the State of the Local Immune Reaction, Journal of Clinical Oncology, vol.29, issue.6, pp.610-618, 2011.
DOI : 10.1200/JCO.2010.30.5425

L. Moretta, C. Bottino, D. Pende, M. Vitale, M. Mingari et al., Human natural killer cells: Molecular mechanisms controlling NK cell activation and tumor cell lysis, Immunology Letters, vol.100, issue.1, pp.7-13, 2005.
DOI : 10.1016/j.imlet.2005.07.004

E. Vivier, D. Raulet, A. Moretta, M. Caligiuri, L. Zitvogel et al., Innate or Adaptive Immunity? The Example of Natural Killer Cells, Science, vol.5, issue.5, pp.44-53, 2011.
DOI : 10.1038/nri1603
URL : https://hal.archives-ouvertes.fr/hal-00611585

E. Vivier, S. Ugolini, D. Blaise, C. Chabannon, and L. Brossay, Targeting natural killer cells and natural killer T cells in cancer, Nature Reviews Immunology, vol.5, issue.4, pp.239-52, 2012.
DOI : 10.1038/nri1603
URL : https://hal.archives-ouvertes.fr/hal-00685473

S. Cooley, D. Weisdorf, L. Guethlein, J. Klein, T. Wang et al., Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia, Blood, vol.116, issue.14, pp.2411-2420, 2010.
DOI : 10.1182/blood-2010-05-283051

C. Fauriat, S. Just-landi, F. Mallet, C. Arnoulet, D. Sainty et al., Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction, Blood, vol.109, issue.1, pp.323-353, 2007.
DOI : 10.1182/blood-2005-08-027979

T. Garcia-iglesias, A. Del-toro-arreola, B. Albarran-somoza, S. Del-toro-arreola, P. Sanchez-hernandez et al., Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions, BMC Cancer, vol.3, issue.5, pp.186-1471, 2009.
DOI : 10.1371/journal.pone.0002150

C. Pasero, G. Gravis, S. Granjeaud, M. Guerin, J. Thomassin-piana et al., Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer, Oncotarget, vol.6, issue.16, pp.14360-73, 2015.
DOI : 10.18632/oncotarget.3965

P. Parham and K. Mcqueen, Alloreactive killer cells: hindrance and help for haematopoietic transplants, Nature Reviews Immunology, vol.345, issue.2, pp.108-130, 2003.
DOI : 10.1056/NEJMoa011826

B. Triplett, E. Horwitz, R. Iyengar, V. Turner, M. Holladay et al., Effects of activating NK cell receptor expression and NK cell reconstitution on the outcomes of unrelated donor hematopoietic cell transplantation for hematologic malignancies, Leukemia, vol.94, issue.7, pp.1278-87, 2009.
DOI : 10.1038/sj.leu.2404892

C. Fauriat, E. Marcenaro, S. Sivori, J. Rey, J. Gastaut et al., Natural Killer Cell-triggering Receptors in Patients with Acute Leukaemia, Leukemia & Lymphoma, vol.146, issue.10, pp.1683-1692, 2003.
DOI : 10.1084/jem.173.6.1339

S. Sivori, D. Pende, C. Bottino, E. Marcenaro, A. Pessino et al., NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells, 05<1656::AID-IMMU1656>3.0.CO, pp.1656-661521, 1999.
DOI : 10.1006/bbrc.1994.2482

A. Martner, A. Rydstr?-om, R. Riise, J. Aurelius, H. Anderson et al., Role of natural killer cell subsets and natural cytotoxicity receptors for the outcome of immunotherapy in acute myeloid leukemia, OncoImmunology, vol.3, issue.1, 2016.
DOI : 10.1182/blood-2009-07-235358

E. Clave, D. Lisini, C. Douay, G. Giorgiani, M. Busson et al., A low thymic function is associated with leukemia relapse in children given T-cell-depleted HLA-haploidentical stem cell transplantation, Leukemia, vol.11, issue.8, pp.1886-1894, 2012.
DOI : 10.1038/nri2970

A. Forcina, M. Noviello, M. Carbone, C. Bonini, and A. Bondanza, Predicting the Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: The Long and Winding Road toward Validated Immune Biomarkers, Frontiers in Immunology, vol.4, p.71, 2013.
DOI : 10.3389/fimmu.2013.00071

L. Blanc, K. Barrett, A. Schaffer, M. Hagglund, H. Ljungman et al., Lymphocyte Recovery Is a Major Determinant of Outcome after Matched Unrelated Myeloablative Transplantation for Myelogenous Malignancies, Biology of Blood and Marrow Transplantation, vol.15, issue.9, pp.1108-1123, 2009.
DOI : 10.1016/j.bbmt.2009.05.015

B. Savani, S. Mielke, S. Adams, M. Uribe, K. Rezvani et al., Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia, Leukemia, vol.174, issue.10, pp.2145-52, 2007.
DOI : 10.1046/j.1440-1711.1999.00865.x

E. Sullivan, S. Jeha, G. Kang, C. Cheng, B. Rooney et al., NK Cell Genotype and Phenotype at Diagnosis of Acute Lymphoblastic Leukemia Correlate with Postinduction Residual Disease, Clinical Cancer Research, vol.20, issue.23, pp.5986-94, 2014.
DOI : 10.1158/1078-0432.CCR-14-0479

H. Ghadially, M. Ohana, M. Elboim, R. Gazit, C. Gur et al., NK Cell Receptor NKp46 Regulates Graft-versus-Host Disease, Cell Reports, vol.7, issue.6, pp.1809-1823, 2014.
DOI : 10.1016/j.celrep.2014.05.011
URL : https://doi.org/10.1016/j.celrep.2014.05.011

N. Delahaye, S. Rusakiewicz, I. Martins, C. Menard, S. Roux et al., Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors, Nature Medicine, vol.180, issue.6, pp.700-707, 2011.
DOI : 10.1016/j.micinf.2006.11.002
URL : https://hal.archives-ouvertes.fr/hal-00665651

G. Venton, Y. Labiad, J. Colle, A. Fino, S. Afridi et al., Natural killer cells in acute myeloid leukemia patients: from phenotype to transcriptomic analysis, Immunologic Research, vol.2015, issue.195, pp.1225-1261, 2016.
DOI : 10.1128/MCB.13.11.6690
URL : https://hal.archives-ouvertes.fr/hal-01460129

Z. Khaznadar, N. Boissel, S. Agaugue, G. Henry, M. Cheok et al., Defective NK Cells in Acute Myeloid Leukemia Patients at Diagnosis Are Associated with Blast Transcriptional Signatures of Immune Evasion, The Journal of Immunology, vol.195, issue.6, pp.2580-90, 2015.
DOI : 10.4049/jimmunol.1500262

S. Avni, Y. Kundu, K. Shemesh, A. Brusilovsky, M. Yossef et al., Expression of NKp46 splice variants in nasal lavage following respiratory viral infection: domain 1-negative isoforms predominate and manifest higher activity, Front Immunol, vol.8, p.161, 2017.

J. Siewiera, J. Gouilly, H. Hocine, G. Cartron, C. Levy et al., Natural cytotoxicity receptor splice variants orchestrate the distinct functions of human natural killer cell subtypes, Nature Communications, vol.6, issue.1, 2014.
DOI : 10.1073/pnas.1110900108

A. Shemesh, M. Brusilovsky, U. Hadad, O. Teltsh, A. Edri et al., Survival in acute myeloid leukemia is associated with NKp44 splice variants, Oncotarget, vol.7, issue.22, 2016.
DOI : 10.18632/oncotarget.8782

K. Ballman, Biomarker: Predictive or Prognostic?, Journal of Clinical Oncology, vol.33, issue.33, p.3651, 2015.
DOI : 10.1200/JCO.2015.63.3651

R. Devillier, V. Gelsi-boyer, A. Murati, T. Prebet, J. Rey et al., Prognostic significance of myelodysplasia-related changes according to the WHO classification among ELN-intermediate-risk AML patients, American Journal of Hematology, vol.116, issue.1, pp.22-26, 2015.
DOI : 10.1182/blood-2010-05-283291

M. Slovak, K. Kopecky, P. Cassileth, D. Harrington, K. Theil et al., Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study, Blood, vol.96, pp.4075-8311110676, 2000.

R. Hills, S. Castaigne, F. Appelbaum, J. Delaunay, S. Petersdorf et al., Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials, The Lancet Oncology, vol.15, issue.9, pp.986-96, 2014.
DOI : 10.1016/S1470-2045(14)70281-5

K. Stringaris, T. Sekine, A. Khoder, A. Alsuliman, B. Razzaghi et al., Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia, Haematologica, vol.99, issue.5, pp.836-883, 2014.
DOI : 10.3324/haematol.2013.087536